We thus designed the current “oncolipidomic” study to analyze the difference in sphingolipid and phospholipid composition in in vitro HCC cells prompted to acquire CSC traits (upon macroH2A1 depletion) or with a suppressed stemness phenotype (upon FAK depletion). This evidence concerns the gene MACROH2A1 and hepatocellular carcinoma.